title: [Negative symptoms: which antipsychotics?].
abstract: Treating negative symptoms of schizophrenia is a major issue and a challenge for the functional and social prognosis of the disease, to which they are closely linked. First- and second-generation antipsychotics allow a reduction of all negative symptoms. The hope of acting directly on primary negative symptoms with any antipsychotic is not supported by the literature. However, the effectiveness of first- and second-generation antipsychotics is demonstrated on secondary negative symptoms.
authors.affiliation: SHU Psychiatrie adultes, Hôpital Ste Marguerite, 13274 Marseille cedex 9, France. Electronic address: muriele.maurel@ap-hm.fr.
authors.forename: M
authors.initials: M
authors.lastname: Maurel
authors.affiliation: SHU Psychiatrie adultes, Hôpital Ste Marguerite, 13274 Marseille cedex 9, France.
authors.forename: R
authors.initials: R
authors.lastname: Belzeaux
authors.affiliation: SHU Psychiatrie adultes, Hôpital Ste Marguerite, 13274 Marseille cedex 9, France.
authors.forename: M
authors.initials: M
authors.lastname: Adida
authors.affiliation: SHU Psychiatrie adultes, Hôpital Ste Marguerite, 13274 Marseille cedex 9, France.
authors.forename: J-M
authors.initials: JM
authors.lastname: Azorin
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents
keywords: Antipsychotiques de première génération; Antipsychotiques de seconde génération; First generation antipsychotics; Primary negative symptoms; Schizophrenia; Schizophrénie; Second generation antipsychotics; Secondary negative symptoms; Symptômes négatifs primaires; Symptômes négatifs secondaires